Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is completed. It is testing paliperidone Blood Concentrations for schizophrenia.
Location not clearly listedThis study is completed. It focuses on Schizophrenia.
Location not clearly listedThis study is completed in the United States, in Colombia, in Malaysia, .... It is testing Paliperidone Palmitate 3 Month Formulation for schizophrenia.
Multiple locations, including Little RockThis study is completed in the United States, in Australia, in France, .... It focuses on Schizophrenia.
Multiple locations, including RogersThis study is completed in Japan. It is testing paliperidone Palmitate for schizophrenia.
Multiple locations, including AsahiThis study is completed in China. It is testing paliperidone Palmitate for schizophrenia.
Multiple locations, including Baoding
This study was withdrawn. It is testing participants With Moderate or Severe Major Depressive Disorder Requiring Urgent Symptom Control for depression.
Location not clearly listedThis study is completed in the United States. It is testing PDC-1421 Treatment for ADHD.
In San FranciscoThis study was terminated in the United States, in Canada, and in Taiwan. It focuses on ADHD.
Multiple locations, including Spring ValleyThis study is completed in the United States and in Canada. It focuses on ADHD.
Multiple locations, including Spring ValleyThis study was terminated in the United States. It is testing PF-03463275 for schizophrenia.
Multiple locations, including CerritosThis study is completed. It focuses on Schizophrenia.
Location not clearly listedHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.